Racial differences in neuromyelitis optica spectrum disorder
- 27 November 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 91 (22), e2089-e2099
- https://doi.org/10.1212/wnl.0000000000006574
Abstract
Objective We aimed to evaluate racial differences in the clinical features of neuromyelitis optica spectrum disorder. Methods This retrospective review included 603 patients (304 Asian, 207 Caucasian, and 92 Afro-American/Afro-European), who were seropositive for anti–aquaporin-4 antibody, from 6 centers in Denmark, Germany, South Korea, United Kingdom, United States, and Thailand. Results Median disease duration at last follow-up was 8 years (range 0.3–38.4 years). Asian and Afro-American/Afro-European patients had a younger onset age than Caucasian patients (mean 36, 33, and 44 years, respectively; p < 0.001). During the disease course, Caucasian patients (23%) had a lower incidence of brain/brainstem involvement than Asian (42%) and Afro-American/Afro-European patients (38%) (p < 0.001). Severe attacks (visual acuity ≤0.1 in at least one eye or Expanded Disability Status Scale score ≥6.0 at nadir) at onset occurred more frequently in Afro-American/Afro-European (58%) than in Asian (46%) and Caucasian (38%) patients (p = 0.005). In the multivariable analysis, older age at onset, higher number of attacks before and after immunosuppressive treatment, but not race, were independent predictors of severe motor disabilities at last follow-up. Conclusion A review of a large international cohort revealed that race affected the clinical phenotype, age at onset, and severity of attacks, but the overall outcome was most dependent on early and effective immunosuppressive treatment.Keywords
This publication has 39 references indexed in Scilit:
- Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disordersMultiple Sclerosis Journal, 2017
- The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patientsJournal of Neuroimmunology, 2016
- Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish CohortThe Neurologist, 2015
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpointsMultiple Sclerosis Journal, 2015
- Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and JapanBrain, 2012
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsJournal of Neuroinflammation, 2012
- AQP4 antibody–positive Thai casesNeurology, 2011
- [HLA-DRB1 typing in Caucasians patients with neuromyelitis optica].2011
- “Cloud‐like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis opticaAnnals of Neurology, 2009